Association of the organic cation transporter OCTN genes with Crohn's disease in the Spanish population

Martínez, Alfonso; del Carmen Martín, Maria; Mendoza, Juan L.; Taxonera, Carlos; Díaz-Rubio, Manuel; de la Concha, Emilio G.; Urcelay, Elena
February 2006
European Journal of Human Genetics;Feb2006, Vol. 14 Issue 2, p222
Academic Journal
The SLC22A4 and SLC22A5 genes within the IBD5 risk locus encode the organic cation transporters OCTN1 and OCTN2. Two variants, 1672C>T in SLC22A4 and −207G>C in SLC22A5, were shown to alter these genes' functions and were identified as genetic susceptibility factors for Crohn's disease (CD). We pursued to check both putative etiologic variants in an independent population through a case–control study with 309 Spanish CD patients and 408 ethnically matched healthy subjects. Both polymorphisms were found in partial linkage disequilibrium (D′=0.86). The separate analysis of each OCTN variant evidenced no association. However, when the simultaneous presence of mutant variants in both genes was analyzed, an effect on CD susceptibility was observed (P=0.026, odds ratio (OR) (95% confidence interval (CI))=1.59 (1.03–2.45)). The previously described predisposition conferred by the 5q31-risk haplotype increased in the absence of the etiologic 1672T and −207C alleles (P=0.0006, OR (95% CI)=10.14 (1.97–98.04)). Moreover, the risk contributed by these polymorphisms was higher in the IBD5 wild-type population (P=0.003, OR (95% CI)=2.65 (1.32–5.35)), arguing against the exclusive etiological role of the OCTN variants. The haplotype pattern inferred led to the consideration of these variants as susceptibility markers only in a defined genetic context. Our data support the interpretation of the 1672C>T SLC22A4 and −207G>C SLC22A5 polymorphisms as genetic markers of susceptibility/protection haplotypes.European Journal of Human Genetics (2006) 14, 222–226. doi:10.1038/sj.ejhg.5201529; published online 7 December 2005


Related Articles

  • Prevalence of CARD15/NOD2 Mutations in Caucasian Healthy People. Hugot, Jean-Pierre; Zaccaria, Isabelle; Cavanaugh, Juleen; Yang, Huiying; Vermeire, Séverine; Lappalainen, Maarit; Schreiber, Stefan; Annese, Vito; Jewell, Derek P.; Fowler, Elizabeth V.; Brant, Steven R.; Silverberg, Mark S.; Cho, Judy; Rioux, John D.; Satsangi, Jack; Parkes, Miles // American Journal of Gastroenterology;Jun2007, Vol. 102 Issue 6, p1259 

    BACKGROUND: Crohn's disease (CD) has been associated with CARD15/NOD2 mutations in Caucasians. The R702W, G908R, and 1007fs mutations represent 82% of the mutated chromosomes. The relative risk of developing CD in homozygous or compound heterozygous people has been estimated as between 10 and 40...

  • Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Sashio, Hiroko; Tamura, Kazuo; Ito, Reiko; Yamamoto, Yoshihiro; Bamba, Hiroko; Kosaka, Tadashi; Fukui, Shin; Sawada, Koji; Fukuda, Yoshihiro; Tamura, Kazutami; Satomi, Masamichi; Shimoyama, Takashi; Furuyama, Jun-ichi // Immunogenetics;Mar2002, Vol. 53 Issue 12, p1020 

    The importance of tumor necrosis factor (TNF)-alpha and the TNF receptor gene polymorphisms in the etipathogenesis of inflammatory bowel disease (IBD) has not been elucidated. DNA from peripheral blood samples was obtained from 124 patients with Crohn's disease (CD), 106 patients with ulcerative...

  • Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases. Klein, W; Tromm, A; Griga, T; Fricke, H; Folwaczny, C; Hocke, M; Eitner, K; Marx, M; Duerig, N; Epplen, J T // Genes & Immunity;Aug2001, Vol. 2 Issue 5, p287 

    Imbalances in the regulation of Th1 and Th2 lymphocytes are crucial in inflammatory bowel diseases. Interleukin-4 is secreted by Th2 lymphocytes and downregulates cytokine production from Th I lymphocytes. Functionally relevant polymorphisms have been described in the interleukin-4 and the...

  • Contribution of NKX2-3 Polymorphisms to Inflammatory Bowel Diseases: A Meta-Analysis of 35358 subjects. XiaoCheng Lu; Linjun Tang; Kai Li; JinYu Zheng; Penglai Zhao; Yi Tao; Li-Xin Li // Scientific Reports;1/31/2014, p1 

    Polymorphisms in NKX2-3 gene have been inconsistently associated with Crohn's disease (CD) and ulcerative colitis (UC). To generate large-scale evidence on whether NKX2-3 polymorphisms are associated with CD or UC susceptibility we have conducted a meta-analysis of 17 studies involving 17329...

  • Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis, in Central China. Min Chen; Peyrin-Biroulet, Laurent; Bing Xia; Guéant-Rodriguez, Rosa-Maria; Bronowicki, Jean-Pierre; Bigard, Marc-André; Guéant, Jean-Louis // BMC Medical Genetics;2008, Vol. 9, Special section p1 

    Background: The association of genetic polymorphisms related to metabolism of homocysteine with inflammatory bowel disease has been evidenced in Crohn disease and remains an open question in ulcerative colitis. We evaluated the association of the polymorphisms of MTHFR, MTR, MTRR and TCN2 genes...

  • Polymorphism of the IRGM Gene Might Predispose to Fistulizing Behavior in Crohn's Disease. Latiano, A.; Palmieri, O.; Cucchiara, S.; Castro, M.; D'Incà, R.; Guariso, G.; Dallapiccola, B.; Valvano, M. R.; Latiano, T.; Andriulli, A.; Annese, V. // American Journal of Gastroenterology;Jan2009, Vol. 104 Issue 1, p110 

    OBJECTIVES: Recently, genome-wide association analyses have identified single nucleotide polymorphisms in the IRGM gene (rs1000113 and rs4958847) as strong candidate susceptibility factors for Crohn's disease (CD). The aim of our study was to test whether these variants are associated with...

  • The CC chemokine receptor 5 Δ32 mutation is not associated with inflammatory bowel disease (IBD) in NE England. Craggs, A; Welfare, M; Donaldson, P T; Mansfield, J C // Genes & Immunity;Apr2001, Vol. 2 Issue 2, p114 

    Inflammatory bowel disease (IBD) is a group of chronic inflammatory diseases of the gastrointestinal tract of unknown aetiology. Evidence of abnormalities in immune regulation and cytokine production in patients with IBD has led to investigations of various immuno-regulatory genes as potential...

  • Genetic Polymorphisms Associated With Inflammatory Bowel Disease Do Not Confer Risk for Primary Sclerosing Cholangitis. Karlsen, Tom H.; Hampe, Jochen; Wiencke, Kristine; Schrumpf, Erik; Thorsby, Erik; Lie, Benedicte A.; Broomé, Ulrika; Schreiber, Stefan; Boberg, Kirsten Muri // American Journal of Gastroenterology;Jan2007, Vol. 102 Issue 1, p115 

    OBJECTIVES: Approximately 80% of patients with primary sclerosing cholangitis (PSC) of Northern European origin have concurrent inflammatory bowel disease (IBD). The majority have ulcerative colitis, but there is also an association with Crohn's colitis. The pathogenetic link between PSC and IBD...

  • Thiopurines in Inflammatory Bowel Disease - The Role of Pharmacogenetics and Therapeutic Drug Monitoring. Lindqvist, Malin; Hindorf, Ulf; Almer, Sven; Peterson, Curt // Current Pharmacogenomics;Dec2006, Vol. 4 Issue 4, p285 

    Pharmacogenetics represents the study of variability in drug response due to genetic variations. Inflammatory bowel disease (IBD, i.e. primarily Crohn's disease and ulcerative colitis) is characterized by a chronic or relapsing in-flammation of the digestive tract. The thiopurines...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics